Browsing: Commentary

Commentary

Shadowed by Giants: Desert Plants Versus Rainforest Plants as Targets for Novel Antibacterial Drug Discovery

By Web AdminNovember 10, 2023

Commentary

The 2020 Coronavirus (COVID-19) Global Pandemic, a Call to Arms to Pharmacognosy Researchers – Plant-Based Antiviral Approaches

By wadmin1January 1, 2021

Commentary

‘Colloidal Silver’: Recommendations to Remove This Misleading Term for Describing Nanoparticulate Silver Antimicrobial Agents

By wadmin2May 6, 2017

Commentary

Phytochemical investigations of species of semi-arid Australian plants: A neglected area of research.

By wadmin1January 1, 2012

Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.